Shilpa Medicare Ltd
Smita Holey is an accomplished executive in the pharmaceutical industry with extensive experience in international markets. Currently serving as Executive Vice President and Head of International ROW Markets at SHILPA MEDICARE LTD since January 2023, Smita has held prominent positions such as Executive Vice President and Vice President of the International Strategic Business Unit at Cadila Pharmaceuticals Limited from September 2017 to January 2023. Previously, Smita was Vice President of International Business Development at Rusan Pharma Ltd and Sr. Manager of International Marketing at Sri Krishna Pharmaceuticals Ltd. Earlier career milestones include serving as International Sales Manager at Garware Technical Fibres Limited. Smita holds an MBA in Foreign Trade from ASM Group of Institutes and a Bachelor of Science from Kamalnayan Bajaj School in India.
This person is not in any offices
Shilpa Medicare Ltd
Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The Company's segments include Bulk Drug/Intermediates and Energy. It offers 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug Delivery Systems, Peptides/Biotech products and Specialty Chemicals. The Company supplies oncology/non-oncology APIs and intermediates. Its oncology API products include Anastrozole, Axitinib, Azacitidine, Abiraterone Acetate, Bicalutamide, Bortezomib, Busulphan, Cabazitaxel Amorphous, Capecitabine, Carboplatin, Cladribine, Clofarabine, Zoledronic acid, Vismodegib, Pemetrexed DiPotassium Nonahydrate, Cyclophosphamide Monohydrate and Cytarabine. It also offers AntiRetroVirals. Its non-oncology API products include Acebrophylline, Echothiophate, Nifedipine, Perfenidone, PrucaloprideSuccinate, Sildenafil Citrate, Ursodeoxycholic acid and Dimethyl Fumarate.